Latest Breaking News On - Alis corporation - Page 1 : comparemela.com

QurAlis to Present Data That Show TDP-43 Pathology Drives Loss of Synaptic UNC13A Function in Neurodegenerative Diseases Including ALS and Frontotemporal Dementia

/PRNewswire/ QurAlis Corporation, a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that will alter.

United kingdomSandy hinckleyQurali asosInternational symposiumPrnewswire quralis corporationAlis corporationMis splicing drives synaptic dysfunctionCell biologySplice modulator platformModulator platform

QurAlis to Present at the Piper Sandler 35th Annual Healthcare Conference

CAMBRIDGE - QurAlis Corporation, a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that will alter the trajectory of amyotrophic lateral.

New yorkUnited statesUnited kingdomPiper sandlerKasper roetKathy vincentHarvard medical schoolHarvard universityQuralis corporationAlis corporationAnnual healthcare conferenceMedical schoolNews publishing

QurAlis to Present Data Showing Link Between TDP-43 Pathology and Role of UNC13A in Neuronal Biology Related to ALS and Other Neurodegenerative Diseases

QurAlis to Present Data Showing Link Between TDP-43 Pathology and Role of UNC13A in Neuronal Biology Related to ALS and Other Neurodegenerative Diseases
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomDaniel elbaumQuralis corporationHarvard medical schoolPrnewswire quralis corporationHarvard universityAlis corporationBiennial conferenceSplice modulator platformModulator platform

QurAlis Receives Clinical Trial Authorisation (CTA) in the U K for QRL-201, a First-in-Class STATHMIN-2 Precision Therapy for ALS

/PRNewswire/ QurAlis Corporation, a clinical-stage biotechnology company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS).

United kingdomComunidad autonoma de catalunaAngela gengeKasper roetKevin egganHealthcare products regulatory agencyEuropean unionEggan labEuropean network to curePrnewswire quralis corporationAlis corporationClinical trial applicationTherapeutic sectionEuropean networkTrial authorisation

QurAlis and Unlearn Announce Collaboration to Accelerate and Optimize ALS Clinical Trials With Generative Artificial Intelligence Technologies

QurAlis and Unlearn Announce Collaboration to Accelerate and Optimize ALS Clinical Trials With Generative Artificial Intelligence Technologies
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomCharles fisherKasper roetQuralis corporationHarvard universityHarvard medical schoolAlis corporation